Shwachman syndrome

Search Trials
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Chronic Myeloid Leukemia (CML)
Intervention(s):
CliniMACS CD34+ Reagent SystemThiotepaCyclophosphamideAlemtuzumabTacrolimusMelphalanBusulfanFludarabineMethylprednisolone
Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
Status:
Active, not recruiting
Last Changed:
Jan 1, 1970
First Changed:
Apr 9, 2014
Disease(s):
Primary Immune Deficiency Disorders
Intervention(s):
BPX-501 and AP1903
Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Dec 6, 2009
Disease(s):
Hematopoietic Cell Transplantation Recipient
Intervention(s):
Allogeneic Bone Marrow TransplantationAnti-Thymocyte GlobulinCyclosporineFludarabine PhosphateLaboratory Biomarker AnalysisMethotrexateMycophenolate MofetilPeripheral Blood Stem Cell TransplantationTacrolimusTotal-Body IrradiationTreosulfanUmbilical Cord Blood Transplantation
Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Shwachman Syndrome
Intervention(s):
filgrastim
Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Nov 7, 2007
Disease(s):
Dyskeratosis Congenita
Intervention(s):
polymerase chain reactionflow cytometryimmunologic techniquebiopsy

Connect. Empower. Inspire.